Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Financial Data and Stock Exchanges

CME Group Inc. operates a derivatives exchange that trades futures contracts and options on futures, interest rates, stock indexes, foreign exchange, and commodities. The Company brings together buyers and sellers of derivatives products on its trading floors, electronic trading platform, and through privately negotiated transactions that it clears.
Website: cmegroup.com



Growth: Pretty weak revenue growth rate 8.1%, there is slowdown compared to average historical growth rates 9.8%. The revenue growth dynamics is moderately stable Site traffic for the last 3 months showed a change of +8.3%

Profitability: LTM net profit margin is positive, +61.3%. In the last quarter the company beat the estimated EPS, +2.1%. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.06 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 1.8%.

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 62.6% higher than minimum and 2.3% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, Net Income margin, industries and geography on average are valued 4.9x by P / Sales multiple , the company can be 69.5% overvalued

Insiders: For the last 3 months insiders sold company shares on $8.7 mln (-0.009% of cap.)

Key Financials (Download financials)

Ticker: CME
Share price, USD:  (0.0%)284.05
year average price 270.14  


year start price 244.83 2025-02-07

min close price 241.74 2025-02-11

max close price 290.71 2025-06-02

current price 284.05 2026-02-07
Common stocks: 359 633 000

Dividend Yield:  1.8%
P / E LTM: 26.5x
P / E annualized: 21.6x
Last revenue growth (y/y):  +10.8%
Last growth of Net Income (y/y):  +38.4%
Historical revenue growth:  +9.8%
Historical growth of Net Income:  +8.7%
P / Sales: 16.2x
Margin (Net Income LTM / Revenue): 61.3%
Fundamental value created in LTM:
Market Cap ($m): 102 154
Price to Book: 3.6x

Revenue and Net Income

Quarterly values ($m)

Change (y/y)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-02-05seekingalpha.com

CME Group: Quality Shines Through, But It Doesn't Mean To Buy

2026-02-04zacks.com

CME Group Q4 Earnings and Revenues Top Estimates, ADV Rises Y/Y

2026-02-04seekingalpha.com

CME Group Inc. (CME) Q4 2025 Earnings Call Transcript

2026-02-04zacks.com

CME Group (CME) Q4 Earnings and Revenues Top Estimates

2026-01-27prnewswire.com

CME Group Reaches New Record in Metals Futures and Options

2026-01-21prnewswire.com

CME Group Sets New Record in Natural Gas Futures and Options

2026-01-15kitco.com

Key factors for investors seeking relative value in precious metals in 2026 – CME Group's Norland

2026-01-13kitco.com

CME to launch cash-settled 100-ounce silver futures targeting retail investors

2025-12-31kitco.com

Silver, platinum and palladium ‘became meme stocks' and CME was forced to ‘preserve the integrity of those markets' – Phoenix Futures' Grady

2025-12-31marketbeat.com

Gold, Silver, and Copper Are Surging—Here Are 3 Smart Ways to Play It
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q4 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-12-31 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol CME CME CME CME CME CME CME CME CME CME CME CME CME CME CME
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
filingDate 2026-02-04 2025-02-27 2024-02-28 2023-02-27 2022-02-25 2021-02-26
acceptedDate 2026-02-04 07:06:41 2025-10-24 14:07:37 2025-07-24 20:01:19 2025-02-27 16:30:05 2024-11-08 15:23:02 2024-08-05 16:48:32 2024-05-01 13:55:31 2024-02-28 15:24:36 2023-11-01 14:56:44 2023-08-02 11:51:37 2023-05-03 14:22:58 2023-02-27 17:01:05 2022-11-02 16:11:08 2022-02-25 14:51:32 2021-02-26 13:01:46
fiscalYear 2025 2024 2023 2022 2021 2020
period FY Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 6 521M 1 538M 1 692M 6 130M 1 584M 1 533M 1 488M 5 579M 1 338M 1 360M 1 442M 5 019M 1 228M 4 690M 4 884M
costOfRevenue 907M 238M 222M 850M 219M 269M 266M 829M 206M 206M 205M 753M 190M 837M 857M
grossProfit 5 614M 1 300M 1 470M 5 280M 1 366M 1 264M 1 222M 4 750M 1 132M 1 155M 1 237M 4 266M 1 038M 3 853M 4 027M
researchAndDevelopmentExpenses 0 0 0 0 0 64M 59M 0 56M 0 0 0 0 0 0
generalAndAdministrativeExpenses 151M 37M 37M 133M 31M 35M 33M 144M 32M 38M 38M 137M 166M 152M 191M
sellingAndMarketingExpenses 0 0 0 0 0 218M 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 151M 37M 37M 133M 31M 35M 33M 144M 32M 38M 38M 137M 166M 152M 191M
otherExpenses 1 234M 291M 304M 1 216M 310M -937M -263M 1 170M -1 156M -1 425M 285M 1 113M 134M 1 056M 1 198M
operatingExpenses 1 384M 327M 341M 1 348M 341M 327M 263M 1 315M 312M 316M 323M 1 250M 299M 1 208M 1 390M
costAndExpenses 2 291M 565M 563M 2 199M 560M 532M 528M 2 143M 518M 522M 528M 2 004M 489M 2 045M 2 246M
netInterestIncome -130M -161M -159M -163M -167M -166M
interestIncome 0 0 0 0 0 1 045M 1 071M 0 1 273M 0 0 0 0 0 0
interestExpense 130M 44M 44M 161M 40M 40M 40M 159M 40M 40M 40M 163M 40M 167M 166M
depreciationAndAmortization 275M 83M 83M 337M 84M 84M 85M 353M 88M 32M 32M 363M 272M 385M 464M
ebitda 5 720M 1 304M 1 458M 5 039M 1 301M 1 085M 1 045M 4 666M -170M 871M 946M 4 016M 1 010M 3 926M 3 353M
ebit 5 445M 4 702M 4 313M 3 653M 3 541M 2 888M
nonOperatingIncomeExcludingInterest -1 216M -771M -877M -637M -895M -251M
operatingIncome 4 230M 973M 1 129M 3 932M 1 024M 1 001M 960M 3 436M 820M 839M 914M 3 016M 739M 2 645M 2 637M
totalOtherIncomeExpensesNet 1 101M 204M 201M 610M 153M 154M 154M 718M 194M 218M 243M 474M 141M 728M 85M
incomeBeforeTax 5 331M 1 177M 1 330M 4 541M 1 177M 1 155M 1 113M 4 154M 974M 1 016M 1 157M 3 490M 880M 3 374M 2 722M
incomeTaxExpense 1 273M 269M 305M 1 016M 264M 271M 258M 927M 224M 239M 273M 799M 200M 737M 616M
netIncomeFromContinuingOperations 4 057M 3 526M 3 226M 2 691M 2 637M 2 106M
netIncomeFromDiscontinuedOperations 0 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 -1 000 000 0
netIncome 4 044M 908M 1 012M 3 526M 879M 883M 855M 3 226M 750M 768M 884M 2 691M 680M 2 636M 2 105M
netIncomeDeductions -6M 0 0 0 0 0
bottomLineNetIncome 4 021M 3 482M 3 186M 2 657M 2 617M 2 105M
eps 11.18 2.49 2.81 9.69 2.51 2.43 2.35 8.87 2.06 2.14 2.46 7.41 1.87 7.3 5.88
epsDiluted 11.16 9.67 8.86 7.4 7.29 5.87
weightedAverageShsOut 360M 360M 360M 359M 359M 359M 359M 359M 359M 359M 359M 359M 359M 358M 358M
weightedAverageShsOutDil 360M 360M 360M 360M 360M 360M 360M 360M 360M 359M 359M 359M 359M 359M 359M
fillingDate 2025-10-24 2025-07-25 2024-11-08 2024-08-05 2024-05-01 2023-11-01 2023-08-02 2023-05-03 2022-11-02
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
grossProfitRatio 0.845 0.869 0.862 0.825 0.821 0.846 0.849 0.858 0.846
ebitdaratio 0.848 0.862 0.821 0.708 0.702 -0.127 0.64 0.656 0.823
operatingIncomeRatio 0.633 0.667 0.646 0.653 0.645 0.613 0.617 0.634 0.602
incomeBeforeTaxRatio 0.765 0.786 0.743 0.753 0.748 0.728 0.747 0.803 0.717
netIncomeRatio 0.591 0.598 0.555 0.576 0.575 0.561 0.564 0.613 0.554
epsdiluted 2.49 2.81 2.5 2.42 2.35 2.06 2.14 2.46 1.87
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link

Balance Sheet Statement

Property 2025 q4 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-12-31 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol CME CME CME CME CME CME CME CME CME CME CME CME CME CME CME
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
filingDate 2026-02-04 2025-02-27 2024-02-28 2023-02-27 2022-02-25 2021-02-26
acceptedDate 2026-02-04 07:06:41 2025-10-24 14:07:37 2025-07-24 20:01:19 2025-02-27 16:30:05 2024-11-08 15:23:02 2024-08-05 16:48:32 2024-05-01 13:55:31 2024-02-28 15:24:36 2023-11-01 14:56:44 2023-08-02 11:51:37 2023-05-03 14:22:58 2023-02-27 17:01:05 2022-11-02 16:11:08 2022-02-25 14:51:32 2021-02-26 13:01:46
fiscalYear 2025 2024 2023 2022 2021 2020
period FY Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 4 423M 2 453M 1 981M 2 892M 2 322M 1 795M 1 442M 2 912M 2 300M 1 880M 1 565M 2 720M 2 130M 2 835M 1 633M
shortTermInvestments 125M 123M 118M 113M 112M 122M 121M 112M 104M 107M 105M 96M 91M 115M 101M
cashAndShortTermInvestments 4 548M 2 577M 2 099M 3 006M 2 434M 1 917M 1 563M 3 024M 2 404M 1 987M 1 670M 2 816M 2 221M 2 950M 1 734M
netReceivables 639M 643M 668M 573M 629M 600M 628M 536M 558M 599M 724M 483M 580M 435M 461M
accountsReceivables 0 573M 536M 483M 435M 461M
otherReceivables 639M 0 0 0 0 0
inventory 0 0 0 0 0 0 0 0 87 197M 113 247M 128 096M 0 0 0 0
prepaids 0 0 0 0 0 0
otherCurrentAssets -5 188M 149 581M 142 684M 99 455M 100 079M 86 238M -2 191M 91 331M 617M 533M 542M 135 779M 140 451M 158 377M 87 089M
totalCurrentAssets 0 152 801M 145 450M 103 034M 103 143M 88 749M 97 308M 94 890M 90 777M 116 366M 131 032M 139 078M 143 253M 161 762M 89 284M
propertyPlantEquipmentNet 363M 355M 363M 386M 386M 634M 396M 410M 417M 430M 440M 456M 466M 505M 579M
goodwill 10 515M 10 515M 10 524M 10 487M 10 514M 10 489M 10 490M 10 495M 10 478M 10 491M 10 491M 10 483M 10 447M 10 528M 10 799M
intangibleAssets 19 786M 17 175M 19 904M 19 997M 17 175M 20 108M 20 165M 20 226M 20 271M 20 336M 20 393M 20 445M 20 478M 20 707M 22 041M
goodwillAndIntangibleAssets 30 301M 27 690M 30 428M 30 484M 27 689M 30 596M 30 655M 30 721M 30 748M 30 826M 30 883M 30 928M 30 925M 31 235M 32 839M
longTermInvestments 0 0 0 0 0 -5 309M -80 268M 0 -5 333M -5 344M 0 0 0 0 0
taxAssets 0 0 0 0 0 5 309M 5 317M 0 5 333M 5 344M 5 357M 0 0 0 0
otherNonCurrentAssets -30 663M 6 299M 3 666M 3 544M 6 577M 3 400M 78 646M 3 686M 3 656M 3 674M -1 673M 3 714M 3 788M 3 278M 1 957M
totalNonCurrentAssets 0 34 344M 34 457M 34 414M 34 652M 34 631M 34 746M 34 816M 34 821M 34 931M 35 008M 35 097M 35 179M 35 019M 35 376M
otherAssets 198 424M 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 198 424M 187 145M 179 907M 137 447M 137 795M 123 379M 132 054M 129 706M 125 598M 151 297M 166 039M 174 176M 178 432M 196 780M 124 660M
totalPayables 0 80M 91M 121M 49M 69M
accountPayables 0 75M 92M 80M 130M 100M 111M 91M 54M 51M 97M 121M 95M 49M 69M
otherPayables 0 0 0 0 0 0
accruedExpenses 0 0 0 0 0 0
shortTermDebt 0 0 0 750M 750M 805M 749M 0 55M 0 16M 16M 15M 749M 0
capitalLeaseObligationsCurrent 0 0 0 0 0 0
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 0 0 0 0 0 650M 638M 0 -55M 0 0 0 0 0 0
otherCurrentLiabilities 160 297M 149 512M 142 703M 101 484M 99 942M 86 069M 94 603M 93 326M 87 827M 113 835M 128 930M 137 550M 140 463M 159 600M 88 129M
totalCurrentLiabilities 160 297M 149 587M 142 795M 102 314M 100 822M 86 974M 96 101M 93 417M 87 881M 113 886M 129 044M 137 688M 140 573M 160 398M 88 198M
longTermDebt 3 422M 3 421M 3 420M 2 678M 2 678M 3 045M 2 677M 3 425M 3 425M 3 424M 3 423M 3 422M 3 422M 2 696M 3 444M
capitalLeaseObligationsNonCurrent 0 0 0 0 0 0
deferredRevenueNonCurrent 0 0 0 0 0 423M -95 352M 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 5 242M 5 220M 5 233M 5 247M 5 310M 5 309M 5 317M 5 328M 5 333M 5 344M 5 357M 5 361M 5 352M 5 390M 5 607M
otherNonCurrentLiabilities -8 665M 726M 720M 721M 769M 415M 96 156M 798M 809M 826M 831M 826M 9 499M 897M 1 059M
totalNonCurrentLiabilities 0 9 367M 9 373M 8 646M 8 757M 8 770M 8 798M 9 551M 9 566M 9 593M 9 611M 9 610M 9 608M 8 983M 10 110M
otherLiabilities 9 399M 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 0 0 0 0 0 423M 390M 0 413M 0 0 0 0 0 0
totalLiabilities 169 696M 158 954M 152 168M 110 960M 109 579M 95 744M 104 900M 102 968M 97 447M 123 479M 138 655M 147 297M 150 181M 169 381M 98 308M
treasuryStock 0 0 0 0 0 0
preferredStock 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
commonStock 0 4M 4M 4M 4M 4M 4M 4M 4M 4M 4M 4M 4M 4M 4M
retainedEarnings 0 5 706M 5 255M 4 186M 5 848M 5 355M 4 891M 4 455M 5 956M 5 607M 5 230M 4 747M 6 112M 5 152M 4 996M
additionalPaidInCapital 0 22 403M 22 335M 22 262M 22 190M 21 186M
accumulatedOtherComprehensiveIncomeLoss 0 43M 45M -106M -11M -95M -86M -56M -117M -100M -131M -133M -100M 54M 135M
otherTotalStockholdersEquity 28 728M 0 0 0 0 0
totalStockholdersEquity 28 728M 28 190M 27 739M 26 487M 28 216M 27 636M 27 154M 26 738M 28 152M 27 818M 27 384M 26 879M 28 251M 27 399M 26 320M
totalEquity 28 728M 28 190M 27 739M 26 487M 28 216M 27 636M 27 154M 26 738M 28 152M 27 818M 27 384M 26 879M 28 251M 27 399M 26 352M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 32M
totalLiabilitiesAndTotalEquity 198 424M 187 145M 179 907M 137 447M 137 795M 123 379M 132 054M 129 706M 125 598M 151 297M 166 039M 174 176M 178 432M 196 780M 124 660M
totalInvestments 125M 123M 118M 113M 112M 122M 121M 112M 104M 107M 105M 96M 91M 115M 101M
totalDebt 3 422M 3 421M 3 420M 3 428M 3 427M 3 850M 3 426M 3 425M 3 425M 3 424M 3 439M 3 438M 3 436M 3 445M 3 444M
netDebt -1 001M 968M 1 439M 536M 1 105M 2 055M 1 984M 513M 1 125M 1 544M 1 874M 718M 1 306M 610M 1 811M
fillingDate 2025-10-24 2025-07-25 2024-11-08 2024-08-05 2024-05-01 2023-11-01 2023-08-02 2023-05-03 2022-11-02
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
othertotalStockholdersEquity 22 437M 22 435M 22 375M 22 372M 22 346M 22 309M 22 308M 22 282M 22 235M
totalLiabilitiesAndStockholdersEquity 187 145M 179 907M 137 795M 123 379M 132 054M 125 598M 151 297M 166 039M 178 432M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol CME CME CME CME CME CME CME CME CME CME CME CME CME CME
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-24 2025-07-25 2024-11-08 2024-08-05 2024-05-01 2023-11-01 2023-08-02 2023-05-03 2022-11-02
acceptedDate 2025-10-24 14:07:37 2025-07-24 20:01:19 2025-02-27 16:30:05 2024-11-08 15:23:02 2024-08-05 16:48:32 2024-05-01 13:55:31 2024-02-28 15:24:36 2023-11-01 14:56:44 2023-08-02 11:51:37 2023-05-03 14:22:58 2023-02-27 17:01:05 2022-11-02 16:11:08 2022-02-25 14:51:32 2021-02-26 13:01:46
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome 908M 1 025M 3 526M 913M 877M 855M 3 226M 750M 778M 884M 2 691M 680M 2 637M 2 106M
depreciationAndAmortization 83M 83M 337M 84M 84M 85M 353M 88M 89M 89M 363M 90M 385M 464M
deferredIncomeTax -7M -13M -66M -7M -7M -7M -75M -9M -9M -9M -23M -10M 35M -42M
stockBasedCompensation 24M 21M 90M 20M 19M 23M 83M 19M 20M 20M 84M 19M 75M 96M
changeInWorkingCapital -14M -52M -192M -19M -193M -65M -95M -10M -218M -23M -95M -114M -162M 59M
accountsReceivables 26M 101M -39M 0 28M -93M -52M 41M 126M -241M -51M 600 000 -46M 28M
inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 -19M
accountsPayables -18M -8M -11M 0 -11M 21M -31M 3M -46M -24M 73M 14M -19M 7M
otherWorkingCapital -22M -145M -142M -19M -210M 12M -13M -54M -298M 243M -117M -129M -98M 43M
otherNonCashItems -26M -6M -4M 12M 160M 4M -38M 18M -9M -59M 37M -7M -568M 31M
netCashProvidedByOperatingActivities 968M 1 059M 3 691M 1 003M 777M 893M 3 454M 857M 650M 902M 3 056M 658M 2 402M 2 716M
investmentsInPropertyPlantAndEquipment -18M -18M -94M -30M -18M -20M -76M -20M -21M -15M -90M -24M -127M -198M
acquisitionsNet -1 000 000 0 10M 0 -100 000 -4M 96M -400 000 0 -2M -402M 0 145M 21M
purchasesOfInvestments -1M -800 000 -5M 0 -2M -1M -4M -400 000 -2M -300 000 -4M -800 000 -8M -11M
salesMaturitiesOfInvestments 1M 1M 6M 0 15M 2M 6M 800 000 101M 700 000 6M 1M 9M 12M
otherInvestingActivites 0 0 300 000 13M -23M 400 000 0 0 0
netCashUsedForInvestingActivites -19M -18M -30M -5M -23M -20M 78M -17M -24M
debtRepayment -2M 0 0 0 0 0 -16M 0 0
commonStockIssued 0 0 0 0 0 0 0 0 0
commonStockRepurchased -8M -9M -33M 0 -100 000 -12M -21M -17M 0 0 -25M 0 0 -41M
dividendsPaid -455M -455M -419M -419M -2 328M -400M -400M -2 036M -363M
otherFinancingActivites 6 865M 21 463M 13 766M -8 804M 4 265M -26 049M -14 846M -7 163M 1 524M
netCashUsedProvidedByFinancingActivities 6 400M 20 999M 13 347M -9 223M 1 936M -26 467M -15 263M -9 199M 1 161M
effectOfForexChangesOnCash -6 883M -21 464M 0 0 0 0 0 26 380M 16 087M 0 0 0 0 0
netChangeInCash 466M 576M 8 684M 14 321M 353M 2 806M -44 865M -25 630M -14 534M -8 313M -22 816M 1 795M 72 370M 82M
cashAtEndOfPeriod 2 453M 1 988M 101 794M 101 786M 1 795M 95 916M 93 110M 89 497M 115 127M 129 661M 137 974M 142 110M 160 790M 1 639M
cashAtBeginningOfPeriod 1 988M 1 412M 93 110M 87 465M 1 442M 93 110M 137 974M 115 127M 129 661M 137 974M 160 790M 140 315M 88 420M 1 557M
operatingCashFlow 968M 1 059M 3 691M 1 003M 777M 893M 3 454M 857M 650M 902M 3 056M 658M 2 402M 2 716M
capitalExpenditure -18M -18M -94M -30M -18M -20M -76M -20M -21M -15M -90M -24M -127M -198M
freeCashFlow 950M 1 040M 3 597M 973M 759M 873M 3 377M 837M 630M 887M 2 966M 634M 2 275M 2 518M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-27 2024-02-28 2023-02-27 2022-02-25 2021-02-26
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 0 0 0 39M 0
netCashProvidedByInvestingActivities -83M 21M -490M 58M -176M
netDebtIssuance 0 -16M -15M 0 -305M
longTermNetDebtIssuance 0 -16M -15M 0 -305M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance -33M -21M -25M 965M -41M
netCommonStockIssuance -33M -21M -25M 965M -41M
commonStockIssuance 0 0 0 965M 0
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid -3 584M -3 236M -2 634M -2 189M -2 110M
commonDividendsPaid -3 584M -3 236M -2 634M -2 189M -2 110M
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 8 694M -45 066M -22 708M 71 133M -2M
netCashProvidedByFinancingActivities 5 077M -48 339M -25 382M 69 909M -2 458M
incomeTaxesPaid 1 198M 1 109M 973M 755M 653M
interestPaid 130M 130M 133M 133M 133M

Earning call transcript

2025 q4
2026-02-04 ET (fiscal 2025 q4)
2025 q3
2025-10-22 ET (fiscal 2025 q3)
2025 q2
2025-07-23 ET (fiscal 2025 q2)
2025 q1
2025-04-23 ET (fiscal 2025 q1)
2024 q4
2025-02-12 ET (fiscal 2024 q4)
2024 q3
2024-10-23 ET (fiscal 2024 q3)
2024 q2
2024-07-24 ET (fiscal 2024 q2)
2024 q1
2024-04-24 ET (fiscal 2024 q1)
2023 q4
2024-02-14 ET (fiscal 2023 q4)
2023 q3
2023-10-25 ET (fiscal 2023 q3)
2023 q2
2023-07-26 ET (fiscal 2023 q2)
2023 q1
2023-04-26 ET (fiscal 2023 q1)
2022 q4
2023-02-08 ET (fiscal 2022 q4)
2022 q3
2022-10-26 ET (fiscal 2022 q3)
2022 q2
2022-07-27 ET (fiscal 2022 q2)
2022 q1
2022-04-27 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2026-02-04 07:06 ET
CME published news for 2025 q4
SEC form 8
2026-02-04 07:06 ET
CME reported for 2025 q4
SEC form 8
2026-02-02 09:31 ET
CME published news for 2025 q4
SEC form 10
2025-10-24 14:07 ET
CME published news for 2025 q3
SEC form 8
2025-10-22 11:05 ET
CME published news for 2025 q3
SEC form 8
2025-10-22 11:05 ET
CME reported for 2025 q3
SEC form 10
2025-07-25 00:01 ET
CME published news for 2025 q2
SEC form 8
2025-07-23 11:08 ET
CME published news for 2025 q2
SEC form 8
2025-07-23 11:08 ET
CME reported for 2025 q2
SEC form 10
2025-04-30 18:50 ET
CME reported for 2025 q1
SEC form 10
2025-04-30 00:00 ET
CME reported for 2025 q1
SEC form 8
2025-04-23 11:07 ET
CME published news for 2025 q1
SEC form 8
2025-04-23 11:07 ET
CME reported for 2025 q1
SEC form 8
2025-04-14 12:35 ET
CME published news for 2025 q1
SEC form 8
2025-04-14 12:35 ET
CME published news for 2025 q1
SEC form 8
2025-03-10 20:12 ET
CME published news for 2024 q4
SEC form 8
2025-03-10 20:12 ET
CME published news for 2024 q4
SEC form 8
2025-03-10 20:12 ET
CME published news for 2024 q4
SEC form 8
2025-03-04 21:30 ET
CME published news for 2024 q4
SEC form 8
2025-03-04 21:30 ET
CME published news for 2024 q4
SEC form 10
2025-02-27 21:30 ET
CME published news for 2024 q4
SEC form 10
2025-02-27 00:00 ET
CME published news for 2024 q4
SEC form 8
2025-02-12 07:05 ET
CME published news for 2024 q4
SEC form 8
2025-02-12 07:05 ET
CME reported for 2024 q4
SEC form 10
2024-11-08 15:23 ET
CME published news for 2024 q3
SEC form 8
2024-10-23 07:06 ET
CME published news for 2024 q3
SEC form 8
2024-10-23 07:06 ET
CME reported for 2024 q3
SEC form 10
2024-08-05 00:00 ET
CME published news for 2024 q2
SEC form 8
2024-07-24 07:10 ET
CME published news for 2024 q2
SEC form 8
2024-07-24 07:10 ET
CME reported for 2024 q2
SEC form 10
2024-05-01 00:00 ET
CME published news for 2024 q1
SEC form 8
2024-04-24 07:05 ET
CME published news for 2024 q1
SEC form 8
2024-04-24 07:05 ET
CME reported for 2024 q1
SEC form 10
2024-02-28 15:24 ET
CME published news for 2023 q4
SEC form 10
2024-02-28 00:00 ET
CME published news for 2023 q4
SEC form 8
2024-02-14 00:00 ET
CME published news for 2023 q4
SEC form 8
2024-02-14 00:00 ET
CME reported for 2023 q4
SEC form 10
2023-11-01 00:00 ET
CME published news for 2023 q3
SEC form 8
2023-10-25 07:05 ET
CME reported for 2023 q3
SEC form 10
2023-08-02 00:00 ET
CME published news for 2023 q2
SEC form 6
2023-07-26 07:04 ET
CME reported for 2023 q2
SEC form 8
2023-07-26 00:00 ET
CME published news for 2023 q2
SEC form 10
2023-05-03 00:00 ET
CME published news for 2023 q1
SEC form 8
2023-04-26 00:00 ET
CME published news for 2023 q1
SEC form 6
2023-03-30 16:08 ET
CME published news for 2022 q4
SEC form 6
2023-03-10 16:38 ET
CME published news for 2022 q4
SEC form 6
2023-02-28 17:06 ET
CME published news for 2022 q4
SEC form 10
2023-02-27 17:01 ET
CME published news for 2022 q4
SEC form 10
2023-02-27 00:00 ET
CME reported for 2022 q4
SEC form 6
2023-02-08 07:15 ET
CME published news for 2022 q4
SEC form 8
2023-02-08 00:00 ET
CME reported for 2022 q4
SEC form 6
2023-02-03 08:07 ET
CME published news for 2022 q4
SEC form 6
2022-12-09 09:52 ET
CME published news for 2022 q3
SEC form 6
2022-11-29 09:30 ET
CME published news for 2022 q3
SEC form 10
2022-11-02 16:11 ET
CME published news for 2022 q3
SEC form 10
2022-11-02 00:00 ET
CME reported for 2022 q3
SEC form 6
2022-10-26 07:06 ET
CME published news for 2022 q3
SEC form 8
2022-10-26 00:00 ET
CME reported for 2022 q3
SEC form 10
2022-08-03 13:19 ET
CME published news for 2022 q2
SEC form 10
2022-08-03 00:00 ET
CME reported for 2022 q2
SEC form 6
2022-07-27 07:06 ET
CME published news for 2022 q2
SEC form 8
2022-07-27 00:00 ET
CME reported for 2022 q2
SEC form 6
2022-05-06 16:05 ET
CME published news for 2022 q1
SEC form 10
2022-05-04 12:30 ET
CME published news for 2022 q1
SEC form 10
2022-05-04 00:00 ET
CME reported for 2022 q1
SEC form 6
2022-04-28 16:05 ET
CME published news for 2022 q1
SEC form 6
2022-04-27 07:07 ET
CME published news for 2022 q1
SEC form 8
2022-04-27 00:00 ET
CME reported for 2022 q1
SEC form 6
2022-04-14 16:39 ET
CME published news for 2022 q1
SEC form 6
2022-03-17 16:48 ET
CME published news for 2021 q4
SEC form 6
2022-03-17 16:47 ET
CME published news for 2021 q4
SEC form 6
2022-03-17 16:47 ET
CME published news for 2021 q4
SEC form 6
2022-03-17 16:46 ET
CME published news for 2021 q4
SEC form 6
2022-03-17 16:46 ET
CME published news for 2021 q4
SEC form 6
2022-03-17 16:45 ET
CME published news for 2021 q4
SEC form 6
2022-03-17 16:44 ET
CME published news for 2021 q4
SEC form 6
2022-03-17 16:44 ET
CME published news for 2021 q4
SEC form 6
2022-03-17 16:43 ET
CME published news for 2021 q4
SEC form 6
2022-03-17 16:43 ET
CME published news for 2021 q4
SEC form 6
2022-03-17 16:42 ET
CME published news for 2021 q4
SEC form 6
2022-03-17 14:42 ET
CME published news for 2021 q4
SEC form 6
2022-03-16 15:40 ET
CME published news for 2021 q4
SEC form 6
2022-03-09 20:05 ET
CME published news for 2021 q4
SEC form 6
2022-03-09 15:46 ET
CME published news for 2021 q4
SEC form 6
2022-03-08 16:01 ET
CME published news for 2021 q4
SEC form 6
2022-03-02 16:05 ET
CME published news for 2021 q4
SEC form 10
2022-02-25 14:51 ET
CME published news for 2021 q4
SEC form 10
2022-02-25 00:00 ET
CME published news for 2021 q4
SEC form 6
2022-02-17 10:30 ET
CME published news for 2021 q4
SEC form 6
2022-02-09 07:11 ET
CME published news for 2021 q4
SEC form 8
2022-02-09 00:00 ET
CME published news for 2021 q4
SEC form 6
2022-02-03 16:31 ET
CME published news for 2021 q4
SEC form 6
2021-11-16 10:58 ET
CME published news for 2021 q3
SEC form 6
2021-11-04 09:14 ET
CME published news for 2021 q3
SEC form 10
2021-11-03 12:31 ET
CME published news for 2021 q3
SEC form 10
2021-11-03 00:00 ET
CME published news for 2021 q3
SEC form 6
2021-10-27 07:08 ET
CME published news for 2021 q3
SEC form 8
2021-10-27 00:00 ET
CME published news for 2021 q3
SEC form 10
2021-08-05 00:00 ET
CME published news for 2021 q2
SEC form 10
2021-08-04 18:00 ET
CME published news for 2021 q2
SEC form 6
2021-07-28 07:07 ET
CME published news for 2021 q2
SEC form 8
2021-07-28 00:00 ET
CME published news for 2021 q2
SEC form 6
2021-06-21 06:09 ET
CME published news for 2021 q1
SEC form 6
2021-05-10 11:05 ET
CME published news for 2021 q1
SEC form 10
2021-05-05 14:51 ET
CME published news for 2021 q1
SEC form 10
2021-05-05 00:00 ET
CME published news for 2021 q1
SEC form 6
2021-04-29 14:34 ET
CME published news for 2021 q1
SEC form 6
2021-04-28 07:20 ET
CME published news for 2021 q1
SEC form 8
2021-04-28 00:00 ET
CME published news for 2021 q1
SEC form 6
2021-03-18 18:35 ET
CME published news for 2020 q4
SEC form 10
2021-02-26 13:01 ET
CME published news for 2020 q4
SEC form 6
2021-02-10 07:12 ET
CME published news for 2020 q4
SEC form 6
2020-11-10 08:01 ET
CME published news for 2020 q3
SEC form 10
2020-11-04 11:51 ET
CME published news for 2020 q3
SEC form 6
2020-10-28 07:07 ET
CME published news for 2020 q3